These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 26366059
1. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer. You Q, Guo H, Xu D. Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059 [Abstract] [Full Text] [Related]
2. Distinct prognostic values of ALDH1 isoenzymes in breast cancer. Wu S, Xue W, Huang X, Yu X, Luo M, Huang Y, Liu Y, Bi Z, Qiu X, Bai S. Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316 [Abstract] [Full Text] [Related]
3. Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer. Shen JX, Liu J, Li GW, Huang YT, Wu HT. Oncotarget; 2016 May 03; 7(18):25340-9. PubMed ID: 27015121 [Abstract] [Full Text] [Related]
4. Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer. Ma YM, Zhao S. Onco Targets Ther; 2016 May 03; 9():1981-8. PubMed ID: 27110126 [Abstract] [Full Text] [Related]
5. The prognostic roles of ALDH1 isoenzymes in gastric cancer. Li K, Guo X, Wang Z, Li X, Bu Y, Bai X, Zheng L, Huang Y. Onco Targets Ther; 2016 May 03; 9():3405-14. PubMed ID: 27354812 [Abstract] [Full Text] [Related]
6. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. Xiong J, Zhang X, Chen X, Wei Y, Lu DG, Han YW, Xu J, Yu D. Oncotarget; 2017 Feb 21; 8(8):13157-13165. PubMed ID: 28061457 [Abstract] [Full Text] [Related]
7. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers. Shimizu H, Yamagishi S, Chiba H, Ghazizadeh M. Adv Clin Exp Med; 2016 Feb 21; 25(1):117-28. PubMed ID: 26935506 [Abstract] [Full Text] [Related]
8. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter. Hou GX, Liu P, Yang J, Wen S. PLoS One; 2017 Feb 21; 12(3):e0174515. PubMed ID: 28355294 [Abstract] [Full Text] [Related]
9. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer. Rebollido-Rios R, Venton G, Sánchez-Redondo S, Iglesias I Felip C, Fournet G, González E, Romero Fernández W, Borroto Escuela DO, Di Stefano B, Penarroche-Díaz R, Martin G, Ceylan I, Costello R, Perez-Alea M. Oncogene; 2020 Mar 21; 39(13):2756-2771. PubMed ID: 32015486 [Abstract] [Full Text] [Related]
12. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR, Ma NF, Chen JW, Li BK, Guan XY, Liu MZ, Xie D. Oncotarget; 2015 Oct 13; 6(31):31181-90. PubMed ID: 26360781 [Abstract] [Full Text] [Related]
15. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer. Zhou L, Yu L, Zhu B, Wu S, Song W, Gong X, Wang D. BMC Cancer; 2016 Nov 10; 16(1):876. PubMed ID: 27832750 [Abstract] [Full Text] [Related]
18. PDE3A is hypermethylated in cisplatin resistant non-small cell lung cancer cells and is a modulator of chemotherapy response. Tian FM, Zhong CY, Wang XN, Meng Y. Eur Rev Med Pharmacol Sci; 2017 Jun 10; 21(11):2635-2641. PubMed ID: 28678321 [Abstract] [Full Text] [Related]